Lobaric acid
Based on 1 Customer Validation
Lobaric acid is a depsipeptide metabolite isolated from Stereocaulon lichen with antioxidant, antiproliferative, antiviral and enzyme inhibitory activities. Lobaric acid scavenges superoxide free radicals (IC50=97.9 μM) and inhibits cancer cell proliferation (EC50 of 15.2-63.9 μg/mL against leukemia, colorectal, gastric, breast, ovarian, prostate, pancreatic and lung cancer cell lines). Lobaric acid inhibits protein tyrosine phosphatase 1B (PTP1B; IC50=0.87 μM for human recombinant enzyme) and 12(S)-HETE produced by 12(S)-lipoxygenase (IC50=28.5 μM). Lobaric acid (250 μM) also reduced pathological changes in tobacco leaves infected with tobacco mosaic virus (TMV).
For research use only. We do not sell to patients.
- Purity: 95.2%
- CAS No.: 522-53-2
- Formula: C25H28O8
- Molecular Weight:456.49
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BXPC-3 | EC50 |
1.6 μM
Compound: 4
|
Cytotoxicity against human BxPC3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human BxPC3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 27300079] |
| HCT-116 | EC50 |
0.8 μM
Compound: 4
|
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 27300079] |
| HT-29 | EC50 |
2.39 μM
Compound: Lobaric acid
|
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
|
[PMID: 24900447] |
| HT-29 | IC50 |
4.54 μM
Compound: Lobaric acid
|
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
|
[PMID: 24900447] |
| J82 | EC50 |
3.6 μM
Compound: 4
|
Cytotoxicity against human J82 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human J82 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 27300079] |
| K562 | EC50 |
1.4 μM
Compound: 4
|
Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 27300079] |
| U2OS | EC50 |
17.6 μM
Compound: Lobaric acid
|
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
|
[PMID: 24900447] |
| UMUC3 | EC50 |
3.7 μM
Compound: 4
|
Cytotoxicity against human UM-UC-3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human UM-UC-3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 27300079] |
Chemical Information
-
CAS No. 522-53-2
-
Appearance Solid
-
Molecular Weight 456.49
-
Formula C25H28O8
-
Color White to off-white
-
SMILES
O=C(C1=C(O)C=C(C(OC2=CC(OC)=CC(C(CCCC)=O)=C23)=C1CCCCC)OC3=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)